Hiroaki Shiohara - Concepedia

Author

Hiroaki Shiohara

Kissei Pharmaceutical (Japan)

Also Known As

H. SHIOHARA, H. Shiohara, Hiroaki Shiohara

Publications

289

Citations

H-Index

Concepts

All Affiliations

Kissei Pharmaceutical (Japan)

About

Hiroaki Shiohara is an author at Kissei Pharmaceutical (Japan) specializing in drug discovery, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	141
2	Natural Sciences	5	5	136
3	Biochemistry	5	5	141
4	Engineering	2	2	66
5	Applied Physics	2	2	66

Hiroaki Shiohara

Publications

260

Citations

H-Index

Page 1

	Year	Citations
Tetrathienylethylenes, a New Class of Electron Donors—Dications Twisted by 90° Stabilized by Formation of Polymethine Units Takanori Suzuki, Hiroaki Shiohara, Masayuki Monobe, Angewandte Chemie International Edition in English Materials ScienceOrganic Charge-transfer CompoundEngineeringApplied PhysicsMolecule-based Material	1992	52
A novel Syk family kinase inhibitor: Design, synthesis, and structure–activity relationship of 1,2,4-triazolo[4,3-c]pyrimidine and 1,2,4-triazolo[1,5-c]pyrimidine derivatives Akihito Hirabayashi, Harunobu Mukaiyama, Hiroaki Kobayashi, Bioorganic & Medicinal Chemistry Structure–activity RelationshipMolecular PharmacologyMedicinal ChemistryBiochemistryMedicine	2008	41
Structure–activity relationship studies of imidazo[1,2-c]pyrimidine derivatives as potent and orally effective Syk family kinases inhibitors Akihito Hirabayashi, Harunobu Mukaiyama, Hiroaki Kobayashi, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryDerivativesBiochemistryMedicine	2008	34
Discovery of Novel 2-Anilinopyrazolo[1,5-a]pyrimidine Derivatives as c-Src Kinase Inhibitors for the Treatment of Acute Ischemic Stroke Harunobu Mukaiyama, Toshihiro Nishimura, Hiroaki Shiohara, Chemical and Pharmaceutical Bulletin	2007	31
Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia Hiroaki Shiohara, Tetsuya Nakamura, Norihiko Kikuchi, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryDerivativesBiochemistryMedicine	2012	26
Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats Issei Tachibana, Takahiko Akiyama, Kenji Kanagawa, American Journal of Physiology-Gastrointestinal and Liver Physiology	1996	22
Structure–activity relationship studies of 5-benzylaminoimidazo[1,2-c]pyrimidine-8-carboxamide derivatives as potent, highly selective ZAP-70 kinase inhibitors Akihito Hirabayashi, Harunobu Mukaiyama, Hiroaki Kobayashi, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryDrug TargetBiochemistry	2008	21
Structure–activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia Nobuhiko Fushimi, Hideki Fujikura, Hiroaki Shiohara, Bioorganic & Medicinal Chemistry Pharmaceutical ScienceBiochemistryMedicineDiabetesGlycobiology	2012	19
2-(Thiopyran-4′-yliden)-1,3-dithioles fused with thiophene units: intramolecular S ⋯ S interaction affecting the redox properties and molecular geometries Takanori Suzuki, Tomoo Sakimura, Shoji Tanaka, Journal of the Chemical Society Chemical Communications Inorganic ChemistryStrong Electron DonorsEngineeringNatural SciencesChemical Bond	1994	14

Page 1